Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Department of Epidemiology, Biostatistics and Biodemography, University of Southern Denmark, Odense University Hospital, J.B. Winsløws Vej 9B, DK-5000 Odense C, Denmark.
Semin Arthritis Rheum. 2018 Feb;47(4):538-544. doi: 10.1016/j.semarthrit.2017.06.007. Epub 2017 Jun 23.
To determine the concordance of systemic lupus erythematosus (SLE) and co-aggregating autoimmune diseases among Danish twins.
SLE-affected twins were ascertained by record linkage between the National Patient Register (NPR) and the Danish Twin Registry (DTR). Registered SLE codes were validated through medical chart review and information from the treating physicians. Twin pairs with at least one chart-validated SLE proband were invited to participate in a personal interview and clinical validation of the SLE diagnoses.
Twenty-two twins fulfilled the ACR criteria for SLE. The age- and sex-adjusted point SLE prevalence in the Danish twin cohort was 30.3 per 100,000 persons (95% CI: 19.2-46.5). Among seven monozygotic (MZ), eight same-sex dizygotic (DZss) and five opposite-sex dizygotic (DZos) twin pairs, one MZ and one DZss were concordant for SLE. This corresponded to probandwise concordance rates of 25.0% (95% CI: 7.15-59.1) and 7.7% (95% CI: 1.37-33.3), and pairwise concordance rates of 14.3% (95% CI: 2.57-51.3) and 7.7% (95% CI: 1.37-33.3) among MZ and DZ twins, respectively. An SLE diagnosis was clinically validated in 17 twins from 15 twin pairs. Another four co-twins had other autoimmune disease, corresponding to a probandwise concordance of any autoimmune disease of 50.0% in MZ (95% CI: 21.5-78.5) and 23.1% in DZ twins (95% CI: 8.18-50.3).
Population-based Danish data suggest that SLE twin concordance is lower than previously reported, but still point to the importance of both genetic and environmental factors, and indicate a substantial co-aggregation of other autoimmune diseases in SLE twins.
确定丹麦双胞胎中系统性红斑狼疮(SLE)和共聚集自身免疫性疾病的一致性。
通过国家患者登记处(NPR)和丹麦双胞胎登记处(DTR)之间的记录链接确定受影响的 SLE 双胞胎。通过病历审查和治疗医生的信息验证登记的 SLE 代码。邀请至少有一个图表验证的 SLE 先证者的双胞胎对参加个人访谈和 SLE 诊断的临床验证。
22 对双胞胎符合 ACR 系统性红斑狼疮标准。丹麦双胞胎队列的年龄和性别调整后的点 SLE 患病率为每 100,000 人 30.3(95%CI:19.2-46.5)。在七对同卵(MZ)、八对同性双卵(DZss)和五对异性双卵(DZos)双胞胎中,一对 MZ 和一对 DZss 与 SLE 一致。这相当于先证者的一致性率为 25.0%(95%CI:7.15-59.1)和 7.7%(95%CI:1.37-33.3),以及 MZ 和 DZ 双胞胎的配对一致性率分别为 14.3%(95%CI:2.57-51.3)和 7.7%(95%CI:1.37-33.3)。在 15 对双胞胎中的 17 对双胞胎中临床验证了 SLE 诊断。另外四对双胞胎患有其他自身免疫性疾病,这对应于 MZ 双胞胎中任何自身免疫性疾病的先证者一致性为 50.0%(95%CI:21.5-78.5)和 DZ 双胞胎中的 23.1%(95%CI:8.18-50.3)。
基于人群的丹麦数据表明,SLE 双胞胎的一致性低于先前报道,但仍表明遗传和环境因素的重要性,并表明 SLE 双胞胎中其他自身免疫性疾病的大量聚集。